wet AMD

The latest news about wet AMD: headlines, AI summaries and the full story from every source.

• EyePoint Pharmaceuticals Announces Strategic Shift to DURAVYU DME Following Phase III Wet AMD Trial Failures Seeking Alpha · November 12, 2026, 16:50 UTC
• Ocular Therapeutix Reports Positive Phase 3 Trial Results for AXPAXLI in Wet AMD Yahoo Finance · April 20, 2026, 00:10 UTC